[국제]EU officially approves AstraZeneca vaccine, recommends vaccination over 18 years of age

[앵커]

The EU has officially approved the conditional sale of the AstraZeneca COVID-19 vaccine.

Johnson & Johnson’s Corona 19 vaccine, which is known to generate immunity with just one hit, has an average preventive effect of 66%.

I will connect you to the International Department to find out more about the news. Reporter Kim Hyung-geun!

EU EU approved AstraZeneca vaccine after Pfizer and Modena vaccine?

[기자]

Yes. That’s right.

First, the European Medicines Agency approved the conditional sale of the COVID-19 vaccine jointly developed by AstraZeneca and Oxford University.

And soon afterwards the EU Commission of the European Union made the same decision.

It has approved a third vaccine after Pfizer and Modena vaccine.

The European Medicines Agency approved the AstraZeneca vaccine and recommended that the vaccine be given to those over 18 years of age.

Regarding the controversy over the effectiveness of vaccination for the elderly, he pointed out that there is a lack of data from clinical trials on how effective it is in the age group over 55.

However, he says, in the light of other vaccines, it is expected to have a protective effect on the elderly as well.

The average preventive effect of this vaccine is 70.4%, which is less than that of Pfizer, Moder or vaccine.

The EU has signed a contract to purchase 400 million vaccine doses with AstraZeneca on behalf of the member states.

However, there continues to be friction over shrinking initial supply.

[앵커]

The average preventive effect of the COVID-19 vaccine developed by the American pharmaceutical company Johnson & Johnson was 66%?

[기자]

Yes, it is.

Regional Phase 3 clinical trials showed 72% in the US, 66% in Latin America, and 57% in South Africa.

The company said that it was 85% effective in preventing severe Corona 19.

It’s lower than Pfizer, modders, or vaccines that were previously approved for emergency use in the United States, but it’s powerful enough, according to the US media.

However, the New York Times pointed out that the problem was that the prevention effect in South Africa had fallen dramatically.

South Africa is where the mutant virus, which is much more contagious, was first discovered, and the virus is now spreading to more than 30 countries, including the United States.

Therefore, the results of clinical trials in South Africa that showed lower preventive effects than other regions suggest that they may be relatively vulnerable to the South African mutant virus.

Johnson & Johnson said it plans to apply for emergency use approval with the FDA as early as next week.

The company expected that it could be approved by the end of February after review by the authorities.

Unlike other vaccines, Johnson & Johnson vaccine is one of the most awaited vaccines around the world because it can be immunized with only one dose and can be distributed and stored at room temperature.

[앵커]

The US Biden administration is taking a life and death to speed up vaccination to prevent the spread of the mutant virus?

[기자]

Yes, it is.

The White House Corona 19 Response Team believes that collective immunity through vaccines is the answer to prevent the spread of the mutant virus, a new variable in the Corona 19 outbreak.

Because mutations originating in the UK and South Africa believe the virus could spread enormously within a few months.

Currently, more than 2 million people have been vaccinated in the United States.

It took a month to inoculate 10 million people, but recently, the speed has increased to more than 20 million people in 10 days.

However, in order to form collective immunity, 70-80% of the population must be vaccinated, but children, which make up a quarter of the population, have not yet been vaccinated.

The U.S. government aims to open most schools around the end of April, but by this time it plans to have children vaccinated as well.

So far, the International Department has delivered it.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]